Atlas Trials

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

Clinical trial NCT04843709 · COMPLETED

Trial details

NCT number
NCT04843709
Sponsor
Lepu Biopharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced or Metastatic Solid Tumors
Start date
2021-07-26
Primary completion
2024-03-20
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.